COVID-19 Impact on Global Psoriasis Therapeutics Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: CD4C1218DCD2EN
QYResearch

Abstracts

This report focuses on the global Psoriasis Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriasis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Astellas Pharma Inc.
• AstraZeneca plc
• Boehringer Ingelheim GmbH
• F. Hofffmann-La Roche
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Valeant Pharmaceuticals International, Inc.
• Biocon Limited
• Eli Lilly and Company
• G & W Laboratories Inc.

Market segment by Type, the product can be split into

• TNF Inhibitors
• PDE4 Inhibitors
• Interleukin Blockers
• Others

Market segment by Application, split into

• Oral
• Parenteral
• Topical

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Psoriasis Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Psoriasis Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Psoriasis Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 TNF Inhibitors
  1.4.3 PDE4 Inhibitors
  1.4.4 Interleukin Blockers
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Oral
  1.5.3 Parenteral
  1.5.4 Topical
1.6 Coronavirus Disease 2019 (Covid-19): Psoriasis Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the Psoriasis Therapeutics Industry
    1.6.1.1 Psoriasis Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Psoriasis Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Psoriasis Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Psoriasis Therapeutics Market Perspective (2015-2026)
2.2 Psoriasis Therapeutics Growth Trends by Regions
  2.2.1 Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Psoriasis Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Psoriasis Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Psoriasis Therapeutics Players by Market Size
  3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Psoriasis Therapeutics Market Concentration Ratio
  3.2.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2019
3.3 Psoriasis Therapeutics Key Players Head office and Area Served
3.4 Key Players Psoriasis Therapeutics Product Solution and Service
3.5 Date of Enter into Psoriasis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)

5 PSORIASIS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Psoriasis Therapeutics Market Size by Application (2015-2020)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Psoriasis Therapeutics Market Size (2015-2020)
6.2 Psoriasis Therapeutics Key Players in North America (2019-2020)
6.3 North America Psoriasis Therapeutics Market Size by Type (2015-2020)
6.4 North America Psoriasis Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Psoriasis Therapeutics Market Size (2015-2020)
7.2 Psoriasis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Psoriasis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Psoriasis Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Psoriasis Therapeutics Market Size (2015-2020)
8.2 Psoriasis Therapeutics Key Players in China (2019-2020)
8.3 China Psoriasis Therapeutics Market Size by Type (2015-2020)
8.4 China Psoriasis Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Psoriasis Therapeutics Market Size (2015-2020)
9.2 Psoriasis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Psoriasis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Psoriasis Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Psoriasis Therapeutics Market Size (2015-2020)
10.2 Psoriasis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Psoriasis Therapeutics Market Size (2015-2020)
11.2 Psoriasis Therapeutics Key Players in India (2019-2020)
11.3 India Psoriasis Therapeutics Market Size by Type (2015-2020)
11.4 India Psoriasis Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Psoriasis Therapeutics Market Size (2015-2020)
12.2 Psoriasis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Psoriasis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Psoriasis Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astellas Pharma Inc.
  13.1.1 Astellas Pharma Inc. Company Details
  13.1.2 Astellas Pharma Inc. Business Overview and Its Total Revenue
  13.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
  13.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020))
  13.1.5 Astellas Pharma Inc. Recent Development
13.2 AstraZeneca plc
  13.2.1 AstraZeneca plc Company Details
  13.2.2 AstraZeneca plc Business Overview and Its Total Revenue
  13.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
  13.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.2.5 AstraZeneca plc Recent Development
13.3 Boehringer Ingelheim GmbH
  13.3.1 Boehringer Ingelheim GmbH Company Details
  13.3.2 Boehringer Ingelheim GmbH Business Overview and Its Total Revenue
  13.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
  13.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.3.5 Boehringer Ingelheim GmbH Recent Development
13.4 F. Hofffmann-La Roche
  13.4.1 F. Hofffmann-La Roche Company Details
  13.4.2 F. Hofffmann-La Roche Business Overview and Its Total Revenue
  13.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
  13.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.4.5 F. Hofffmann-La Roche Recent Development
13.5 GlaxoSmithKline plc
  13.5.1 GlaxoSmithKline plc Company Details
  13.5.2 GlaxoSmithKline plc Business Overview and Its Total Revenue
  13.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
  13.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.5.5 GlaxoSmithKline plc Recent Development
13.6 Merck & Co., Inc.
  13.6.1 Merck & Co., Inc. Company Details
  13.6.2 Merck & Co., Inc. Business Overview and Its Total Revenue
  13.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
  13.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.6.5 Merck & Co., Inc. Recent Development
13.7 Valeant Pharmaceuticals International, Inc.
  13.7.1 Valeant Pharmaceuticals International, Inc. Company Details
  13.7.2 Valeant Pharmaceuticals International, Inc. Business Overview and Its Total Revenue
  13.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
  13.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
13.8 Biocon Limited
  13.8.1 Biocon Limited Company Details
  13.8.2 Biocon Limited Business Overview and Its Total Revenue
  13.8.3 Biocon Limited Psoriasis Therapeutics Introduction
  13.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.8.5 Biocon Limited Recent Development
13.9 Eli Lilly and Company
  13.9.1 Eli Lilly and Company Company Details
  13.9.2 Eli Lilly and Company Business Overview and Its Total Revenue
  13.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
  13.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.9.5 Eli Lilly and Company Recent Development
13.10 G & W Laboratories Inc.
  13.10.1 G & W Laboratories Inc. Company Details
  13.10.2 G & W Laboratories Inc. Business Overview and Its Total Revenue
  13.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
  13.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020)
  13.10.5 G & W Laboratories Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Psoriasis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Psoriasis Therapeutics Revenue
Table 3. Ranking of Global Top Psoriasis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of TNF Inhibitors
Table 6. Key Players of PDE4 Inhibitors
Table 7. Key Players of Interleukin Blockers
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Psoriasis Therapeutics Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Psoriasis Therapeutics Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Psoriasis Therapeutics Players to Combat Covid-19 Impact
Table 14. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Psoriasis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Psoriasis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Psoriasis Therapeutics Market Share by Regions (2015-2020)
Table 18. Global Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Psoriasis Therapeutics Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Psoriasis Therapeutics Market Growth Strategy
Table 24. Main Points Interviewed from Key Psoriasis Therapeutics Players
Table 25. Global Psoriasis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 26. Global Psoriasis Therapeutics Market Share by Players (2015-2020)
Table 27. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2019)
Table 28. Global Psoriasis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Psoriasis Therapeutics Product Solution and Service
Table 31. Date of Enter into Psoriasis Therapeutics Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 34. Global Psoriasis Therapeutics Market Size Share by Type (2015-2020)
Table 35. Global Psoriasis Therapeutics Revenue Market Share by Type (2021-2026)
Table 36. Global Psoriasis Therapeutics Market Size Share by Application (2015-2020)
Table 37. Global Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. Global Psoriasis Therapeutics Market Size Share by Application (2021-2026)
Table 39. North America Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 41. North America Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. North America Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 43. North America Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. North America Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 45. Europe Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 47. Europe Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 49. Europe Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 51. China Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 53. China Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. China Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 55. China Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. China Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 57. Japan Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 59. Japan Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 61. Japan Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 65. Southeast Asia Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 67. Southeast Asia Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 69. India Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 70. India Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 71. India Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. India Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 73. India Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. India Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Psoriasis Therapeutics Market Share (2019-2020)
Table 77. Central & South America Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 79. Central & South America Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 81. Astellas Pharma Inc. Company Details
Table 82. Astellas Pharma Inc. Business Overview
Table 83. Astellas Pharma Inc. Product
Table 84. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 85. Astellas Pharma Inc. Recent Development
Table 86. AstraZeneca plc Company Details
Table 87. AstraZeneca plc Business Overview
Table 88. AstraZeneca plc Product
Table 89. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 90. AstraZeneca plc Recent Development
Table 91. Boehringer Ingelheim GmbH Company Details
Table 92. Boehringer Ingelheim GmbH Business Overview
Table 93. Boehringer Ingelheim GmbH Product
Table 94. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 95. Boehringer Ingelheim GmbH Recent Development
Table 96. F. Hofffmann-La Roche Company Details
Table 97. F. Hofffmann-La Roche Business Overview
Table 98. F. Hofffmann-La Roche Product
Table 99. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 100. F. Hofffmann-La Roche Recent Development
Table 101. GlaxoSmithKline plc Company Details
Table 102. GlaxoSmithKline plc Business Overview
Table 103. GlaxoSmithKline plc Product
Table 104. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 105. GlaxoSmithKline plc Recent Development
Table 106. Merck & Co., Inc. Company Details
Table 107. Merck & Co., Inc. Business Overview
Table 108. Merck & Co., Inc. Product
Table 109. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 110. Merck & Co., Inc. Recent Development
Table 111. Valeant Pharmaceuticals International, Inc. Company Details
Table 112. Valeant Pharmaceuticals International, Inc. Business Overview
Table 113. Valeant Pharmaceuticals International, Inc. Product
Table 114. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 115. Valeant Pharmaceuticals International, Inc. Recent Development
Table 116. Biocon Limited Business Overview
Table 117. Biocon Limited Product
Table 118. Biocon Limited Company Details
Table 119. Biocon Limited Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 120. Biocon Limited Recent Development
Table 121. Eli Lilly and Company Company Details
Table 122. Eli Lilly and Company Business Overview
Table 123. Eli Lilly and Company Product
Table 124. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 125. Eli Lilly and Company Recent Development
Table 126. G & W Laboratories Inc. Company Details
Table 127. G & W Laboratories Inc. Business Overview
Table 128. G & W Laboratories Inc. Product
Table 129. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 130. G & W Laboratories Inc. Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Psoriasis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Others Features
Figure 6. Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Oral Case Studies
Figure 8. Parenteral Case Studies
Figure 9. Topical Case Studies
Figure 10. Psoriasis Therapeutics Report Years Considered
Figure 11. Global Psoriasis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Psoriasis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Psoriasis Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Psoriasis Therapeutics Market Share by Players in 2019
Figure 16. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2019
Figure 18. North America Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 27. AstraZeneca plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 29. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 31. F. Hofffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 33. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 35. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 37. Valeant Pharmaceuticals International, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 39. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 41. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 43. G & W Laboratories Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed